Investor Relations

CHF Solutions is an early stage company focused on commercializing the Aquadex FlexFlow® system. Our objective is to improve the quality of life for patients with heart failure and related conditions, such as fluid overload. CHF Solutions is listed on the NASDAQ Capital Market.

Press Releases

Posted on Jan 19, 2018
EDEN PRAIRIE, Minn., Jan. 19, 2018 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ:CHFS), today announced that on January 17, 2018, the independent directors approved equity awards under CHF Solutions' New-Hire Equity Incentive Plan, as material inducements to six individuals entering into employm...

Read More

Posted on Jan 12, 2018
EDEN PRAIRIE, Minn., Jan. 12, 2018 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ:CHFS) announced today that John Erb, Chief Executive Officer, will be a featured presenter at NobleCon14, Noble Capital Markets' Fourteenth Annual Investor Conference, on January 29th at 3:00 PM Eastern Standard Tim...

Read More

Posted on Dec 13, 2017
EDEN PRAIRIE, Minn., Dec. 13, 2017 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ:CHFS) announced today that it has entered into an international distribution agreement with Singapore-based TRANSMEDIC Pte Ltd to market and support CHF Solutions' Aquadex FlexFlow® System in the region. "...

Read More

Events & Presentations